Eiger BioPharmaceuticals Inc. (EIGR) Slipped -49.38% or -7.9 To Price $8.1 On Tuesday


Eiger BioPharmaceuticals Inc. (EIGR) slipped -49.38% or -7.9 to $8.1. It is around 2.66 million shares traded, which is 2676.28% compare to the average total volume 99249. The market cap of EIGR is $85.18 million. The year to date change is 13.88%. The 52 week price range is from $6.1 to $16.2. Price of EIGR have changed 20.30% during last week. It have changed 33.33% over last month, 35.02% over last 3 months, 60.80% over last 6 months and 30.61% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EIGR is 12.28. It is 51.60% above current price. The 200-day Moving Averages for EIGR is 9.78. It is 20.74% above current price. The 52-week High is 16.2. It is 100.00% from the current price. The 52-week Low is 6.1. It is -24.69% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of EIGR is 2.24 on 2017-12-29. Short % to float is 1.46%. There are some statistics of EIGR. It is has market cap $85.18 million. The share outstanding is 10.52 million. The average volume is 99249. The percent of top 15 Institution holding is 42.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EIGR is -137.18%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EIGR is -97.73%.


Tags:

Share this post